Skip to content
Home/Companies/Pharma/Lomapharm
Lomapharm

Lomapharm

Pharma·Germany·Exited 2018·Held 5yr
Entry
2013
Hold
5yr
Exit
2018

Who owns Lomapharm?

Lomapharm is a German Pharma company, now owned by Daicel, which acquired it in 2018 from DUBAG Group.

Hand-verified · updated 2026-07-03

Open JSON · CC-BY
DUBAG Group
Investor
DUBAG Group
Lenbach Equity Opportunities I · 2017 · Evergreen

Key facts

HQGermany
SectorPharma
StatusAcquired
Websitelomapharm.de
Exit Type
Trade Sale
Buyer
Daicel Corporation
Exit Year
2018

More from Lenbach Equity Opportunities I

Other portfolio companies in the same fund.

Scheven
Scheven
Exited 2020
ConstructionGermany· 2017
to Diringer & Scheidel
Schwinn
Schwinn
Exited 2020
ConsumerGermany· 2015
to Private investor
epsotech
epsotech
Active
IndustrialsGermany· 2014
MMC Studios
MMC Studios
Exited 2019
TMTGermany· 2013
to Novum Capital
IDC (International Detergent Compounds)
Exited 2012
IndustrialsGermany· 2010
to Warwick Chemicals

More PE-backed in Pharma

Comparable pharma deals from other GPs.

Abacus Pharmaceuticals
Abacus Pharmaceuticals
Active
The Carlyle GroupUS
AdipoPharma
AdipoPharma
Active
Capital Grand EstFrance
Advantice Health
Advantice Health
Active
TA AssociatesUS
Alcala Farma
Active
Advent InternationalSpain
Alvogen
Alvogen
Active
CVC Capital Partners
Anovo
Anovo
Active
ArdianUS

Questions

Who owns Lomapharm?

Lomapharm is now owned by Daicel, which acquired it in 2018 from DUBAG Group.

When did Daicel acquire Lomapharm?

Daicel acquired Lomapharm in 2018, buying from DUBAG Group.

Who did Lomapharm sell to?

DUBAG Group sold Lomapharm to Daicel in 2018 (Trade Sale).

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue